%1

Proposal to add a MADL for Acrylamide of 140 ug/day

A Maximum Allowable Dose Level (MADL) for chromium (hexavalent compounds) was established.  The amendment will become effective July 29, 2011.

Proposal to establish a MADL of 8.2ug/day for chromium (hexavalent compounds).

This rulemaking action clarifies the original intent of the regulation and allows for the most current and appropriate methodology to be applied to quantitative risk assessment.  This amendment also provides default age-specific bodyweights to be used in calculation of the maximum allowable dose level. The amendment is effective on April 16, 2011. 

 A No Significant Risk Level for imazalil of 11 micrograms per day was adopted effective April 25, 2012.

Proposal to add a NSRL for imazalil of 11ug/day.

A notice to establish a specific regulatory level posing no significant risk for imazalil was posted on the OEHHA website and published in the CRNR on September 9, 2011. OEHHA is withdrawing that notice because a number of non-substantive, clarifying changes to the notice were required.

Adoption of 0.54 micrograms per day as the No Significant Risk Level for glycidol for purposes of Proposition 65.

OEHHA proposal to adopt 0.54 micrograms per day as the No Significant Risk Level for glycidol  for purposes of Proposition 65

Amendment to Section 12705. Specific Regulatory Levels Posing No Significant Risk: benzofuran, N-carboxymethyl-N-nitrosourea, p-chloro-o-toluidine hydrochloride, 3,3'-dimethoxybenzidine; 3,3'-dimethoxybenzidine dihydrochloride, 3,3'-dimethylbenzidine, 3,3'-dimethylbenzidine dihydrochloride, isobutyl nitrite, 2-methylaziridine (propyleneimine), nalidixic acid, phenyl glycidyl ether, o-phenylenediamine, o-phenylenediamine dihydrochloride, tetranitromethane, and 2,6-xylidine and Amendment to Section 12805. Specific Regulatory Levels: Reproductive Toxicants: linuron